New · CUSIP 09062W204 · who reports it, how much, and how much it matters to them
18 of the 720 hedge fund managers we track reported shares of Biolife Solutions Inc (BLFS) on Form 13F for 30 June 2026. Between them they reported USD 184m. The largest position belongs to Casdin Capital, at USD 131m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Casdin Capital3 funds on PPLI.com | USD 131m | 6.6% |
| 2 | Millennium Management6 funds on PPLI.com | USD 18m | 0.0% |
| 3 | Gagnon Advisors4 funds on PPLI.com | USD 7.7m | 4.9% |
| 4 | Heights Point Management1 fund on PPLI.com | USD 6.7m | 5.4% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 4.5m | 0.0% |
| 6 | Squarepoint Ops7 funds on PPLI.com | USD 3.8m | 0.0% |
| 7 | Barings1 fund on PPLI.com | USD 2.6m | 0.0% |
| 8 | Exoduspoint Capital Management7 funds on PPLI.com | USD 2.1m | 0.0% |
| 9 | Verition Fund Management3 funds on PPLI.com | USD 2m | 0.0% |
| 10 | TIG Advisors15 funds on PPLI.com | USD 1.5m | 0.1% |
| 11 | POINT72 Asset Management17 funds on PPLI.com | USD 989,000 | 0.0% |
| 12 | Weiss Asset Management5 funds on PPLI.com | USD 719,000 | 0.0% |
| 13 | Marshall Wace LLP84 funds on PPLI.com | USD 669,000 | 0.0% |
| 14 | Engineers Gate Manager1 fund on PPLI.com | USD 424,000 | 0.0% |
| 15 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 384,000 | 0.0% |
| 16 | D. E. Shaw & Co.15 funds on PPLI.com | USD 349,000 | 0.0% |
| 17 | Boothbay Fund Management2 funds on PPLI.com | USD 238,000 | 0.0% |
| 18 | The Quarry1 fund on PPLI.com | USD 20,615 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Casdin Capital | USD 131m | 6.6% |
| 2 | Heights Point Management | USD 6.7m | 5.4% |
| 3 | Gagnon Advisors | USD 7.7m | 4.9% |
| 4 | TIG Advisors | USD 1.5m | 0.1% |
| 5 | Barings | USD 2.6m | 0.0% |
| 6 | Campbell & Company Investment Adviser | USD 384,000 | 0.0% |
| 7 | Exoduspoint Capital Management | USD 2.1m | 0.0% |
| 8 | Verition Fund Management | USD 2m | 0.0% |
| 9 | Weiss Asset Management | USD 719,000 | 0.0% |
| 10 | Millennium Management | USD 18m | 0.0% |
Biolife Solutions Inc trades under the symbol BLFS. Its CUSIP, the code used on Form 13F, is 09062W204.
18 of the 720 hedge fund managers PPLI.com tracks reported Biolife Solutions Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Casdin Capital (USD 131m), Millennium Management (USD 18m), Gagnon Advisors (USD 7.7m), Heights Point Management (USD 6.7m) and Citadel Advisors (USD 4.5m).
18 managers in our coverage reported it, and between them they run 212 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Casdin Capital, where the position was 6.6% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Biolife Solutions Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.